The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
article. This is especially challenging when the test article is administered via inhalation.<br />
This poster describes the method for achieving a successful outcome in<br />
these types <strong>of</strong> studies, including the factors that must be considered in the design<br />
and execution. Effects <strong>of</strong> proper habituation to equipment and carefully scheduled<br />
study activities were assessed based on the overall character <strong>of</strong> cardiorespiratory response<br />
from 3 different studies.<br />
Prior to the first data collection, all animals were surgically implanted with DSI<br />
telemetry transmitters and habituated to the exposure/data collection system.<br />
Respiratory parameters were collected using respiratory inductance plethysmography<br />
(RIP). Telemetry data were collected continuously while animals were in their<br />
home cage, after transfer to the exposure suite but prior to either air or the vehicle,<br />
during the exposure period, and for 24 hours post dose in 3 different studies. Each<br />
study used a different vehicle and an air (sham) control was administered to assess<br />
the vehicle effect.<br />
Administration <strong>of</strong> the vehicle produced no effects on blood pressure, heart rate,<br />
body temperature, respiratory rate, tidal volume and minute volume during predose,<br />
exposure period and for the 24 hour post dose recording period when compared<br />
to air (sham) control in all 3 studies. Very similar patterns in blood pressure<br />
and heart rate were noted in all 3 studies; however, each study has a specific pattern<br />
for body temperature and respiratory parameters, which was attributed to individual<br />
variation in these parameters. This poster presents a consistent and reliable<br />
method <strong>of</strong> collecting cardiorespiratory data from conscious beagle dogs prior to,<br />
during and after inhalation exposure in our Testing Facility.<br />
71 Assessment <strong>of</strong> QT-Interval Prolongation in Nonclinical<br />
Safety Study Using External Telemetric Device in Conscious<br />
Beagle Dogs: Application <strong>of</strong> QT Shift and Probabilistic<br />
Methods.<br />
L. Renaud 1 , P. Champeroux 2 , S. Ruillon 1 , N. Velasquez 1 , P. Desbois 1 ,<br />
O. Wattrelos 1 and N. Claude 1 . 1 Drug Safety, Servier, Gidy, France; 2 Centre de<br />
Recherches Biologiques, CERB, Baugy, France.<br />
<strong>The</strong> detection <strong>of</strong> delayed ventricular repolarization, characterized by a QT interval<br />
prolongation, is one <strong>of</strong> the main issues for the preclinical evaluation <strong>of</strong> potential<br />
risk <strong>of</strong> pro-arrythmia for a new drug candidate. This study was designed to compare<br />
different methods <strong>of</strong> QT interval prolongation assessment in conscious beagle dogs<br />
using external telemetric device. <strong>The</strong> same 6 dogs (3/sex) were given vehicle or reference<br />
compounds known to induce QT interval prolongation using a sequential<br />
design (single oral dosing <strong>of</strong> Sotalol at 30 mg/kg and Moxifloxacin at 30 then 90<br />
mg/kg or repeated oral dosing for 6 days <strong>of</strong> Thioridazine at 20 mg/kg/d and<br />
Terfenadine at 30 mg/kg/d). Electrocardiograms were recorded during a treatmentfree<br />
period and on day 1 and/or day 6 for approximately 20 h post dosing. QT intervals<br />
were measured from a beat to beat analysis over 10-min periods centred on<br />
selected timeslots and corrected according to the Van de Waters formula (QTvdw).<br />
QT shift calculations and an analysis based on the principles <strong>of</strong> the Holzgrefe’s<br />
probabilistic method (QTh, using a minimum 250 beats/timeslot) were also performed.<br />
All methods allowed an accurate evidence <strong>of</strong> QT effect for Sotalol and<br />
Moxifloxacin. <strong>The</strong> QT shift and QTh methods gave more evidences for<br />
Terfenadine effect than QTvdw. As expected, the marked increase in heart rate<br />
(HR) induced by Thioridazine resulted in no apparent effect on QT and a statistically<br />
significant overcorrection for QTvdw whereas QT shift and QTh gave more<br />
accurate and reliable results. <strong>The</strong> statistical sensitivity threshold detection <strong>of</strong> QT<br />
prolongation was low, i.e. 10 to 15 ms for QT shift and QTh methods. Thus, external<br />
telemetry in non-clinical safety dog studies allows new perspectives for a better<br />
assessment <strong>of</strong> QT prolongation when associated to QT shift and Holzgrefe’s<br />
probabilistic methods, especially in case <strong>of</strong> slight drug-induced QT effect or<br />
marked changes in HR.<br />
72 Integration <strong>of</strong> Automated Patch Clamp Systems and Logistic<br />
Models in the Cardiochannelgramtm (CCGTM) for Better<br />
Prediction <strong>of</strong> Cardiac Risk.<br />
J. W. Kramer 1 , G. J. Myatt 2 , C. A. Obejero-Paz 1 , A. Bruening-Wright 1 ,<br />
Y. A. Kuryshev 1 and A. M. Brown 1 . 1 ChanTest Corporation, Cleveland, OH;<br />
2 Leadscope Inc., Columbus, OH.<br />
Drug-induced inhibition <strong>of</strong> the cardiac hERG potassium channel is recommended<br />
by ICH and FDA to predict delayed cardiac repolarization (DR) and cardiac risk.<br />
<strong>The</strong> consequent QTc prolongation is a surrogate marker <strong>of</strong> Torsade de Pointes<br />
(TdP), a rare but potentially lethal iatrogenic outcome. Drugs with effective therapeutic<br />
plasma concentrations (ETPC) within 30-fold <strong>of</strong> their hERG IC50s are<br />
thought to be dangerous despite the fact that multiple ion channel effects (MICE)<br />
14 SOT 2013 ANNUAL MEETING<br />
can mitigate DR. Here we demonstrate that logistic regression models, which integrate<br />
MICE, predict TdP with much greater certainty than the hERG safety ratio<br />
(hERG IC50/ETPC or safety margin (SM)) alone. To this end we measured hERG,<br />
Nav1.5,Cav1.2, Kir2.1 and KvLQT1/minK IC50 values <strong>of</strong> 56 drugs (33 +TdP and<br />
23 -TdP) from multiple classes using automated patch clamp systems including<br />
Qpatch and PatchXpress. <strong>The</strong> sensitivity <strong>of</strong> the automated patch clamp platforms<br />
was evaluated in a comparison to manual patch clamp. ETPC values and the torsadogenic<br />
liability <strong>of</strong> drugs was obtained from the literature, package inserts and<br />
Arizona CERT. Eleven logistic regression models were constructed; one using the<br />
hERG SM alone, the others integrating hERG SM, Nav1.5 SM and/or Cav1.2 SM<br />
data. <strong>The</strong> predictive power <strong>of</strong> each model was evaluated using the likelihood ratio<br />
test. Leave-one-out cross validations were performed and each model’s accuracy was<br />
determined by comparing receiver–operating characteristics (ROC, sensitivity vs.<br />
1-specificity). Models that include Nav1.5, Cav1.2 or both variables are statistically<br />
significant better predictors <strong>of</strong> TdP liability than the model that contains only<br />
hERG (Model 1). Model 1 had a ROC area under the curve (AUC) <strong>of</strong> 0.80 and<br />
Model 11, that includes hERG, Nav and Cav1.2 SMs, significantly improved accuracy<br />
showing a ROC AUC <strong>of</strong> 0.94. Thus, Model 11 that incorporates the concept<br />
<strong>of</strong> MICE in the CardioChannelGramTM (CCGTM) is a robust nonclinical predictor<br />
<strong>of</strong> cardiac risk.<br />
73 Characterization <strong>of</strong> Jacketed External Telemetry with Blood<br />
Pressure in Conscious Nonhuman Primates in Pen-Style<br />
Housing Administered Etilefrine, Sotalol, or Hydralazine.<br />
L. Kreckler, J. Kopshinsky, J. Schneider, G. Hanson, D. Morris and C. Foley.<br />
Covance Laboratories, Inc., Madison, WI.<br />
An important component <strong>of</strong> nonclinical safety assessment is the evaluation <strong>of</strong> electrocardiography<br />
(ECG) and hemodynamic parameters. Jacketed external telemetry<br />
with an implanted telemetry blood pressure transmitter (JET-BP) is a minimally invasive<br />
technology being utilized in general toxicology studies to assess ECG and<br />
blood pressure measurements in conscious, unrestrained animals. We characterized<br />
JET-BP in nonhuman primates (NHPs) housed in pen-style caging with three reference<br />
compounds with known effects on blood pressure or ECG parameters.<br />
Thirty-six male NHPs were implanted with a telemetry blood pressure device and<br />
group-housed in pen-style caging (3 animals/pen). Four animals per group were<br />
given reference material or a concurrent control article. Etilefrine, a sympathomimetic,<br />
was given at 1 or 10 mg/kg; hydralazine, a vasodilator, at 1 or 10 mg/kg;<br />
and sotalol, a non-specific β-blocker, at 3 or 30 mg/kg. JET-BP measurements were<br />
recorded for at least 90 minutes prior to dosing and continuously for at least 20<br />
hours postdose. <strong>The</strong> following ECG and hemodynamic parameters were determined<br />
as one (light phase) or two-hour (dark phase) averages: PR, QT and rate-corrected<br />
QT; systolic, diastolic, and mean arterial pressures; heart rate; and arterial<br />
pulse pressure. In addition, blood was collected at seven postdose timepoints for<br />
each test article for pharmacokinetic analysis. Etilefrine significantly increased<br />
mean arterial pressure, systolic blood pressure and pulse height, while diastolic<br />
blood pressure remained unchanged. Sotalol significantly prolonged QT with no<br />
significant change in blood pressure. Administration <strong>of</strong> hydralazine did not significantly<br />
change blood pressure at the dose levels administered. In summary, ECG<br />
and blood pressure changes caused by three different reference compounds were detectable<br />
using JET-BP technology in group-housed NHPs.<br />
74 Differential Cardiovascular Physiology and Pathology in<br />
Selected Lineages <strong>of</strong> Miniature Swine.<br />
A. Stricker-Krongrad 1 , T. J. Madsen 1 , B. C. Hanks 1, 2 , D. Brocksmith 2 , J. Liu 1 ,<br />
L. D. Brown 1, 2 and G. F. Bouchard 1, 2 . 1 Sinclair Research Center, LLC, Columbia,<br />
MO; 2 Sinclair BioResources LLC, Auxvasse, MO.<br />
<strong>The</strong> miniature swine has been increasingly recognized as a valid alternative to canine<br />
and non-human primates in regulatory toxicity. This poster presents the results<br />
<strong>of</strong> cardiovascular assessments in the Yucatan, Hanford, and Sinclair miniature<br />
swine conducted during clinical investigations and control toxicity testing.<br />
Anatomic parameters were obtained at necropsy. Blood vessels diameter, velocity,<br />
and flow were obtained by Doppler ultrasonography. Cardiac electrophysiology was<br />
obtained using clinical ECG and surgical monitor units. Macroscopic lesions and<br />
histopathology assessments were conducted on heart and kidneys. Data were compared<br />
to published measurements <strong>of</strong> adult human illustrating similarities or differences<br />
(for practicality, male data are reported here). Across the three lineages, heartto-body<br />
weights ratio ranged from 0.41 to 0.50 and were higher than human<br />
(0.42). <strong>The</strong> geometric corrections for heart rate adjustment to body size ranged<br />
from 215 to 297 and were comparable to human (241), indicating that heart volume<br />
and function were well adjusted to the reduction in body size. <strong>The</strong> miniswine